Pharmacokinetics and safety of the ketolide telithromycin in patients with renal impairment.
about
Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury.Xenobiotic metabolism: the effect of acute kidney injury on non-renal drug clearance and hepatic drug metabolismEffects of chronic kidney disease and uremia on hepatic drug metabolism and transport.Ketolides in the treatment of community-acquired respiratory tract infections: A review.Evaluation of exposure change of nonrenally eliminated drugs in patients with chronic kidney disease using physiologically based pharmacokinetic modeling and simulation.Effects of itraconazole or grapefruit juice on the pharmacokinetics of telithromycin.The bioequivalence of telithromycin administered orally as crushed tablets versus tablets swallowed whole.Effects of Renal Function on Crizotinib Pharmacokinetics: Dose Recommendations for Patients with ALK-Positive Non-Small Cell Lung Cancer.Drug development perspective on pharmacokinetic studies of new drugs in patients with renal impairment.
P2860
Q37336958-F2172E17-0463-473A-BC0C-179B474E62DFQ37645239-685214F9-49BC-4580-B8DC-FFDE84F3FB9BQ38153196-17E62E30-E918-4DCC-8807-1FC50EC52930Q38199663-407C38E1-30F4-4D9B-AB3B-7CFA32CBBA14Q45901623-7D1119DF-4191-4F71-92DE-88FE8C1FFA45Q46378358-CDA88D7E-3A6A-4B2C-9B85-B0904F98BA0BQ46650427-E25476A9-E3CA-4564-BDA1-09163C22BE45Q48107138-D9805AC6-1FD2-4FCA-82CF-04A1CB127786Q51790803-95747D8F-A5CD-4035-9869-3DAE9B701509
P2860
Pharmacokinetics and safety of the ketolide telithromycin in patients with renal impairment.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Pharmacokinetics and safety of ...... atients with renal impairment.
@en
Pharmacokinetics and safety of ...... atients with renal impairment.
@nl
type
label
Pharmacokinetics and safety of ...... atients with renal impairment.
@en
Pharmacokinetics and safety of ...... atients with renal impairment.
@nl
prefLabel
Pharmacokinetics and safety of ...... atients with renal impairment.
@en
Pharmacokinetics and safety of ...... atients with renal impairment.
@nl
P2093
P2860
P356
P1476
Pharmacokinetics and safety of ...... atients with renal impairment.
@en
P2093
Bruno Leroy
Guy Montay
Jeffrey S Barrett
Marshall Sack
Pierre Hardy
Ramon Vargas
Sunny Chapel
Suzanne K Swan
Thomas Marbury
P2860
P304
P356
10.1177/0091270003262952
P577
2004-03-01T00:00:00Z